Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of the efficacy, onset of action and safety of Tot'hema in adults with moderate iron deficiency anaemia
2019-003202-27Phase 4Completed
- Sponsor
- Laboratoire Innotech
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferrous gluconate + manganese gluconate + copper gluconate in iron deficiency anemia (IDA), sponsored by Laboratoire Innotech. Primary endpoint: Time to initial haemoglobin increase. Started Apr 2020; status: completed.
02
Drugs
ferrous gluconate + manganese gluconate + copper gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2019-003202-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003202-27.